Prevalence of undertreatment in cancer pain. A review of published literature
Background: Pain is a major health care problem for patients with cancer: despite the existence of guidelines for cancer pain management, undertreatment is a widespread problem. Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity...
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2008-12, Vol.19 (12), p.1985-1991 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1991 |
|---|---|
| container_issue | 12 |
| container_start_page | 1985 |
| container_title | Annals of oncology |
| container_volume | 19 |
| creator | Deandrea, S. Montanari, M. Moja, L. Apolone, G. |
| description | Background: Pain is a major health care problem for patients with cancer: despite the existence of guidelines for cancer pain management, undertreatment is a widespread problem. Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity/strength of the analgesic therapy. Negative scores indicate inadequate prescriptions. Materials and methods: We conducted a Medline search using terms for ‘pain management’, ‘index’ or ‘measure’ to select studies which measured undertreatment in cancer settings. Univariate and multivariate logistic regression identified associations between independent predictors and high prevalence of undertreatment. Results: Among the 44 studies identified, 26 studies used the PMI as proposed by Cleeland. The range of negative PMI varied from 8% to 82% with a weighted mean value of 43%. In multivariate analyses, factors associated with negative PMI were date of publication before 2001, provenance from Europe or Asia and countries with a gross national income per capita |
| doi_str_mv | 10.1093/annonc/mdn419 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2733110</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdn419</oup_id><sourcerecordid>1602886161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c604t-4a80d6fd35c24cf0b4bc36c0fb3a1d13ca4d358a9919a5830f12d486192965e83</originalsourceid><addsrcrecordid>eNqF0U1v1DAQBmALgei2cOSKIiQQl7R27Dj2pVJVCkVqxYcKQlysWWdCXRJ7sZMC_x6vEi0fF04-zKOZ13oJecToIaOaH4H3wdujofWC6TtkxWqpS0UFu0tWVFe8bGou9sh-SjeUUqkrfZ_sMSV51VRsRS7fRryFHr3FInTF5FuMY0QYB_Rj4XxhIY9isQHnD4uTImuH37d0M617l66xLXo3YoRxiviA3OugT_hweQ_Ih5dnV6fn5cWbV69PTy5KK6kYSwGKtrJreW0rYTu6FmvLpaXdmgNrGbcg8kyB1kxDrTjtWNUKJVlOL2tU_IAcz3tziAFbm7NG6M0mugHiTxPAmb8n3l2bL-HWVA3njNG84NmyIIZvE6bRDC5Z7HvwGKZkpFZMCb2FT_6BN2GKPn_OMC1lTZtmi8oZ2RhSitjtkjBqti2ZuSUzt5T94z_j_9ZLLRk8XQAkC30Xcwku7VxFtaiUFtk9n12YNv-9uWR0acQfOwzxq5ENb2pz_umz4fTq8h1_8d585L8Akxq6SQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196650770</pqid></control><display><type>article</type><title>Prevalence of undertreatment in cancer pain. A review of published literature</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Deandrea, S. ; Montanari, M. ; Moja, L. ; Apolone, G.</creator><creatorcontrib>Deandrea, S. ; Montanari, M. ; Moja, L. ; Apolone, G.</creatorcontrib><description>Background: Pain is a major health care problem for patients with cancer: despite the existence of guidelines for cancer pain management, undertreatment is a widespread problem. Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity/strength of the analgesic therapy. Negative scores indicate inadequate prescriptions. Materials and methods: We conducted a Medline search using terms for ‘pain management’, ‘index’ or ‘measure’ to select studies which measured undertreatment in cancer settings. Univariate and multivariate logistic regression identified associations between independent predictors and high prevalence of undertreatment. Results: Among the 44 studies identified, 26 studies used the PMI as proposed by Cleeland. The range of negative PMI varied from 8% to 82% with a weighted mean value of 43%. In multivariate analyses, factors associated with negative PMI were date of publication before 2001, provenance from Europe or Asia and countries with a gross national income per capita <$40 000 per year and a care setting not specific for cancer. Age was not a significant predictor for undertreatment. Conclusion: Nearly one of two patients with cancer pain is undertreated. The percentage is high, but consists of a large variability of undertreatment across studies and settings.</description><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdn419</identifier><identifier>PMID: 18632721</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Analgesics - therapeutic use ; Antineoplastic agents ; Biological and medical sciences ; cancer pain ; Humans ; Medical sciences ; Neoplasms - complications ; Pain - epidemiology ; Pain - etiology ; Pain Management ; palliative care ; Pharmacology. Drug treatments ; Prevalence ; quality of care ; Reviews</subject><ispartof>Annals of oncology, 2008-12, Vol.19 (12), p.1985-1991</ispartof><rights>The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org 2008</rights><rights>2009 INIST-CNRS</rights><rights>The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c604t-4a80d6fd35c24cf0b4bc36c0fb3a1d13ca4d358a9919a5830f12d486192965e83</citedby><cites>FETCH-LOGICAL-c604t-4a80d6fd35c24cf0b4bc36c0fb3a1d13ca4d358a9919a5830f12d486192965e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20942894$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18632721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deandrea, S.</creatorcontrib><creatorcontrib>Montanari, M.</creatorcontrib><creatorcontrib>Moja, L.</creatorcontrib><creatorcontrib>Apolone, G.</creatorcontrib><title>Prevalence of undertreatment in cancer pain. A review of published literature</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>Background: Pain is a major health care problem for patients with cancer: despite the existence of guidelines for cancer pain management, undertreatment is a widespread problem. Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity/strength of the analgesic therapy. Negative scores indicate inadequate prescriptions. Materials and methods: We conducted a Medline search using terms for ‘pain management’, ‘index’ or ‘measure’ to select studies which measured undertreatment in cancer settings. Univariate and multivariate logistic regression identified associations between independent predictors and high prevalence of undertreatment. Results: Among the 44 studies identified, 26 studies used the PMI as proposed by Cleeland. The range of negative PMI varied from 8% to 82% with a weighted mean value of 43%. In multivariate analyses, factors associated with negative PMI were date of publication before 2001, provenance from Europe or Asia and countries with a gross national income per capita <$40 000 per year and a care setting not specific for cancer. Age was not a significant predictor for undertreatment. Conclusion: Nearly one of two patients with cancer pain is undertreated. The percentage is high, but consists of a large variability of undertreatment across studies and settings.</description><subject>Analgesics - therapeutic use</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>cancer pain</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neoplasms - complications</subject><subject>Pain - epidemiology</subject><subject>Pain - etiology</subject><subject>Pain Management</subject><subject>palliative care</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>quality of care</subject><subject>Reviews</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0U1v1DAQBmALgei2cOSKIiQQl7R27Dj2pVJVCkVqxYcKQlysWWdCXRJ7sZMC_x6vEi0fF04-zKOZ13oJecToIaOaH4H3wdujofWC6TtkxWqpS0UFu0tWVFe8bGou9sh-SjeUUqkrfZ_sMSV51VRsRS7fRryFHr3FInTF5FuMY0QYB_Rj4XxhIY9isQHnD4uTImuH37d0M617l66xLXo3YoRxiviA3OugT_hweQ_Ih5dnV6fn5cWbV69PTy5KK6kYSwGKtrJreW0rYTu6FmvLpaXdmgNrGbcg8kyB1kxDrTjtWNUKJVlOL2tU_IAcz3tziAFbm7NG6M0mugHiTxPAmb8n3l2bL-HWVA3njNG84NmyIIZvE6bRDC5Z7HvwGKZkpFZMCb2FT_6BN2GKPn_OMC1lTZtmi8oZ2RhSitjtkjBqti2ZuSUzt5T94z_j_9ZLLRk8XQAkC30Xcwku7VxFtaiUFtk9n12YNv-9uWR0acQfOwzxq5ENb2pz_umz4fTq8h1_8d585L8Akxq6SQ</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Deandrea, S.</creator><creator>Montanari, M.</creator><creator>Moja, L.</creator><creator>Apolone, G.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20081201</creationdate><title>Prevalence of undertreatment in cancer pain. A review of published literature</title><author>Deandrea, S. ; Montanari, M. ; Moja, L. ; Apolone, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c604t-4a80d6fd35c24cf0b4bc36c0fb3a1d13ca4d358a9919a5830f12d486192965e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Analgesics - therapeutic use</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>cancer pain</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neoplasms - complications</topic><topic>Pain - epidemiology</topic><topic>Pain - etiology</topic><topic>Pain Management</topic><topic>palliative care</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>quality of care</topic><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deandrea, S.</creatorcontrib><creatorcontrib>Montanari, M.</creatorcontrib><creatorcontrib>Moja, L.</creatorcontrib><creatorcontrib>Apolone, G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deandrea, S.</au><au>Montanari, M.</au><au>Moja, L.</au><au>Apolone, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of undertreatment in cancer pain. A review of published literature</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>19</volume><issue>12</issue><spage>1985</spage><epage>1991</epage><pages>1985-1991</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><abstract>Background: Pain is a major health care problem for patients with cancer: despite the existence of guidelines for cancer pain management, undertreatment is a widespread problem. Pain Management Indexes (PMIs) evaluate the congruence between the patient's reported level of pain and the intensity/strength of the analgesic therapy. Negative scores indicate inadequate prescriptions. Materials and methods: We conducted a Medline search using terms for ‘pain management’, ‘index’ or ‘measure’ to select studies which measured undertreatment in cancer settings. Univariate and multivariate logistic regression identified associations between independent predictors and high prevalence of undertreatment. Results: Among the 44 studies identified, 26 studies used the PMI as proposed by Cleeland. The range of negative PMI varied from 8% to 82% with a weighted mean value of 43%. In multivariate analyses, factors associated with negative PMI were date of publication before 2001, provenance from Europe or Asia and countries with a gross national income per capita <$40 000 per year and a care setting not specific for cancer. Age was not a significant predictor for undertreatment. Conclusion: Nearly one of two patients with cancer pain is undertreated. The percentage is high, but consists of a large variability of undertreatment across studies and settings.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>18632721</pmid><doi>10.1093/annonc/mdn419</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2008-12, Vol.19 (12), p.1985-1991 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2733110 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Analgesics - therapeutic use Antineoplastic agents Biological and medical sciences cancer pain Humans Medical sciences Neoplasms - complications Pain - epidemiology Pain - etiology Pain Management palliative care Pharmacology. Drug treatments Prevalence quality of care Reviews |
| title | Prevalence of undertreatment in cancer pain. A review of published literature |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T05%3A00%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20undertreatment%20in%20cancer%20pain.%20A%20review%20of%20published%20literature&rft.jtitle=Annals%20of%20oncology&rft.au=Deandrea,%20S.&rft.date=2008-12-01&rft.volume=19&rft.issue=12&rft.spage=1985&rft.epage=1991&rft.pages=1985-1991&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdn419&rft_dat=%3Cproquest_pubme%3E1602886161%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=196650770&rft_id=info:pmid/18632721&rft_oup_id=10.1093/annonc/mdn419&rfr_iscdi=true |